Wells Fargo & Company »

Intensity Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Intensity Therapeutics (INTS) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Intensity Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intensity Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intensity Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.2k 200 5.88

More positions owned by Wells Fargo & Company

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon Put Option (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Core Msci Emkt (IEMG)

View all positions for Wells Fargo & Company

Top funds holding Intensity Therapeutics

Geode Capital Management
Sapient Capital
Sentinus
Vanguard Capital Management
Mesirow Financial Investment Management International Equity
Vanguard Fiduciary Trust
Goss Wealth Management
Wells Fargo & Company
UBS Group
Morgan Stanley

View all funds holding Intensity Therapeutics